The LSI Leadership Council is a group of biomedical industry leaders, venture capitalists and government officials. The council advises and supports the LSI leadership and faculty.

Members

  • Rajesh Alva, CEO and CIO, Avtar Investments
  • L. Kay Chandler, Partner, Cooley LLP
  • Richard Douglas, Ph.D., Board of Directors, Novavax Inc.; Advisor, Red Sky Partners
  • James Flynn, Partner, Deerfield Management Company
  • Lawrence G. Hamann, Ph.D., Head of Drug Discovery Sciences, Takeda
  • Corey M. Horowitz, Chairman and CEO, Network-1
  • Christopher J. Kirk, Ph.D., President and CSO, Kezar Life Sciences
  • Justin E. Klein, Partner, Ice Miller LLP
  • David E. Kroin, Founder and CIO, Deep Track Capital
  • Shiraz Ladiwala, Vice President, Strategy and Corporate Development, Thermo Fisher Scientific
  • Bruce Leuchter, Managing Partner, PJT Partners
  • Greg Margolies, Senior Partner and Head of Capital Markets Group, Ares Management LLC
  • Joel F. Martin, Ph.D., President and CEO, Intrepida Bio Inc.
  • Paul M. Meister, President, MacAndrews & Forbes Holdings Inc.; Co-Founder, Liberty Lane Partners LLC
  • Roger Newton, Ph.D., Founder, Executive Chairman and Chief Scientific Officer, Esperion Therapeutics
  • John E. Osborn, Executive in Residence, Warburg Pincus; Affiliate Professor, University of Washington, Seattle; Contributor, Forbes.com
  • Julia C. Owens, Ph.D., President and CEO, Millendo Therapeutics Inc.
  • Atul Pande, M.D., Chief Medical Advisor, PureTech Health
  • Craig C. Parker, CEO, Surrozen
  • Liam Ratcliffe, M.D., Ph.D., Head of Biotechnology, Access Industries
  • Terry Rosen, Ph.D., CEO, Arcus Biosciences
  • Joseph Schwarz, M.D., Former U.S. Representative, 7th Congressional District, Michigan
  • Barry Sherman, M.D., Co-Founder, CEO and President, StemPar Sciences Inc.
  • Matthew C. Smith, Ph.D., Co-Founder and Director, Tornado Bio Inc.  
  • Michael Staebler, Partner, Pepper Hamilton LLP
  • Burton Sutker, M.D., Radiologist, St. Clare’s Health System, New Jersey
  • David R. Walt, Ph.D., Core Faculty Member, Wyss Institute at Harvard University; Professor of Pathology, Harvard Medical School; Howard Hughes Medical Institute Professor; Founder of Illumina Inc. and Quanterix Corp.
  • Wendell Wierenga, Ph.D., Independent Consultant and former CEO and R&D leader in Biotech and Pharma
  • Steve Worland, Ph.D., President, CEO and Director, eFFECTOR Therapeutics Inc.